Article
Comparison of the Roche Cobas(®) 4800 HPV assay to Digene Hybrid Capture 2, Roche Linear Array and Roche Amplicor for Detection of High-Risk Human Papillomavirus Genotypes in Women undergoing treatment for cervical dysplasia.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Jan 2015
Phillips Samuel, Garland Suzanne M, Tan Jeffery H, Quinn Michael A, Tabrizi Sepehr N
Abstract excerpt
BACKGROUND: The recently FDA (U.S. food and drug administration) approved Roche Cobas(®) 4800 (Cobas) human papillomavirus (HPV) has limited performance data compared to current HPV detection methods for test of cure in women undergoing treatment for high grade lesions. OBJECTIVE: Evaluation of Cobas HPV assay using historical samples from women undergoing treatment for cervical dysplasia. STUDY DESIGN: A...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.